Profile
ACRV VRTX REGN VRNA ARGX ALNY
Company Name Acrivon Therapeutics, Inc. Common Stock Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $49.23M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.08K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Peter Blume-Jensen Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ACRV VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ACRV VRTX REGN VRNA ARGX ALNY
Last Close $2.38 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $7.58 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $1.05 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -68.6 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 126.67 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ACRV VRTX REGN VRNA ARGX ALNY
1 Month Return 31.49 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 71.22 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 106.96 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -54.75 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -60.47 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -62.7 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACRV VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -28.89 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ACRV VRTX REGN VRNA ARGX ALNY
Asset Growth 42.18 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -87.69 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -33.4 % 9.09 % -131.37 % 24.59 %
Net Income Growth -33.4 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share -67.18 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -411.79 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -411.79 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -32.66 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -54 % - -143.33 % -107.98 %
Operating 3 Year CFG -58.33 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -689.77 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -689.77 % -100 % 40.15 % 97.08 %
EPS Growth 23.36 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 23.36 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -15.91 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share 350.3 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 808.37 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 808.37 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -21.51 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -55.79 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ACRV VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -56.26 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -53.71 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -68.21 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 91.9 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -2201 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 1.22 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -1.71 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -1.77 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 335.2 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.46 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -2201 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.72 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -0.91 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -0.91 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
ACRV VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.08B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.08B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -2.1 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ACRV VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.02B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.18B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0.14B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.2B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ACRV VRTX REGN VRNA ARGX ALNY
Net Income $-0.08B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.07B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 25.39
AARD Aardvark Therapeutics, Inc. Common Stock 12.1288
ABCL AbCellera Biologics Inc. 3.0413
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.97
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.3499
ABPWW 0.0132
ABSI Absci Corporation 2.5588
ABUS Arbutus Biopharma Corporation 4.13
ABVC ABVC BioPharma, Inc. 1.685
ABVX Abivax SA American Depositary Shares 116.62
ACAD ACADIA Pharmaceuticals Inc. 22.225
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.93
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.18
ACIU AC Immune SA 2.9502
ETFs With Exposure to ACRV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00008 265.94
VTI Vanguard Total Stock Market Index Fund 0.00005 342.64
IBB iShares Biotechnology ETF 0.0048 169.79
SCHB Schwab U.S. Broad Market ETF 0.0000736968 26.795
SCHA Schwab U.S. Small-Cap ETF 0.000544871 30.965
IWN iShares Russell 2000 Value ETF 0.00017 201.59
IWO iShares Russell 2000 Growth ETF 0.00305 339.48
BIB ProShares Ultra Nasdaq Biotechnology 0.0045116 82.18
VXF Vanguard Extended Market Index Fund 0.00044 219.25
HDG ProShares Hedge Replication ETF 0.0000771473 52.7979
UWM ProShares Ultra Russell2000 0.000435315 54.28
VTHR Vanguard Russell 3000 Index Fund 0 306.995
IWC iShares Micro-Cap ETF 0.01 168.67
URTY ProShares UltraPro Russell2000 0.000348092 65.485
VTWV Vanguard Russell 2000 Value Index Fund 0.00111 177.635
VTWO Vanguard Russell 2000 Index Fund 0.00049 107.46
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 50.31
VUN.TO Vanguard U.S. Total Market Index ETF 0.00005 126.68
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00005 118.92
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00002 115.08
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 115.06
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00008 52.59
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00008 52.59
VBINX Vanguard Balanced Index Fund Investor Shares 0.00008 52.59
RYLD Global X Russell 2000 Covered Call ETF 0 15.7645
VGRO.TO Vanguard Growth ETF Portfolio 0.00002 44.44
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00002 55.96
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.9
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.13
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.39
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.97
IBBQ Invesco Nasdaq Biotechnology ETF 0.005514 29.095
DFAT Dimensional U.S. Targeted Value ETF 0.0000199 67.15
DFAS Dimensional U.S. Small Cap ETF 0.00001232 76.55
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000578 41.46
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 7.192
VTSAX Vanguard Total Stock Market Index Fund 0.00005 166.35
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 8.53
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0059 51.38
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00044 166.39
VITSX Vanguard Total Stock Market Index Fund 0.00005 166.38
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01 8.522
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0059 61.01
DFSU Dimensional US Sustainability Core 1 ETF 0.00003684 44.34
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000104799 16.7
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00044 166.41
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 6.24
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00356256 43.02
AVSC Avantis U.S. Small Cap Equity ETF 0 65.46
VTS.AX Vanguard US Total Market Shares Index ETF 0.00005 482.09
VEMPX Vanguard Extended Market Index InstlPlus 0.00044 410.63
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00005 312.11
RSSL Global X Funds 0 104.275
DXUV Dimensional ETF Trust 0.00002398 63.24
RFLR Innovator ETFs Trust 0 29.985
Unlock